Role of Radiotherapy in the Multimodal Treatment of Ewing Sarcoma Family Tumors
Open Access
- 16 February 2015
- journal article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 47 (4), 904-912
- https://doi.org/10.4143/crt.2014.158
Abstract
The aim of this study was to evaluate the role of radiotherapy (RT) in the management of Ewing sarcoma family tumors (ESFT). Retrospective analysiswas performed on 91 patientswith localized ESFT treated from 1988 to 2012. Primary tumor size was ≥ 8 cm in 33 patients. Surgery, RT, and combined surgery with RT were applied in 37, 15, and 33 patients, respectively. Median follow-up was 43.8 months. Forty-three patients (47.3%) showed recurrence or progressive disease. Twelve patients (13.2%) showed local failure after initial treatment. Thirty-nine patients (42.9%) experienced distant metastases. The 5-year overall survival (OS), progression-free survival, and local control (LC) were 60.5%, 58.2%, and 85.1%, respectively. According to treatment, 5-year LCwas 64.8% with RT and 90.2% with combined surgery and RT (p=0.052). Prognostic factors for OS were tumor size (≥ 8 cm, p < 0.001) and surgical resection (p < 0.001). In large tumors (≥ 8 cm), combined surgery and RT produced better LC compared to RT (p=0.033). However, in smaller tumors (< 8 cm), RT without surgery resulted in a similar LC rate as RT with surgery (p=0.374). RT used for patients with unfavorable risk factors resulted in worse outcome than for patientswho received surgery. Smallertumors could be controlled locallywith chemotherapy and RT. For large tumors, combined surgery and RT is needed. Proper selection of local treatment modality, RT, surgery, or both is crucial in the management of ESFT.Keywords
This publication has 26 references indexed in Scilit:
- Treatment Outcome of Korean Patients with Localized Ewing Sarcoma Family of Tumors: A Single Institution ExperienceJapanese Journal of Clinical Oncology, 2011
- Treatment of nonmetastatic Ewing’s sarcoma family tumors of the spine and sacrum: the experience from a single institutionEuropean Spine Journal, 2009
- Tandem high‐dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high‐risk Ewing family tumorsPediatric Blood & Cancer, 2007
- Treatment of Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor of Bone: Evaluation of Combination Ifosfamide and Etoposide—A Children's Cancer Group and Pediatric Oncology Group StudyJournal of Clinical Oncology, 2004
- Ewing sarcoma: Radiation dose and target volumePediatric Blood & Cancer, 2004
- Role of radiotherapy in Ewing tumorsPediatric Blood & Cancer, 2004
- Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest WallAnnals of Surgery, 2003
- Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of BoneThe New England Journal of Medicine, 2003
- Ewing’s sarcoma of the pelvis: changes over 25 years in treatment and resultsEuropean Journal of Cancer, 1997
- The role of radiation therapy in localized Ewing's sarcomaSeminars in Radiation Oncology, 1997